XENE Operating Cash Flow (Statement)
Xenon Pharmaceuticals Inc · Operating Cash Flow (Statement)
XENE Operating Cash Flow (Statement)
Latest reported-$337.52Mperiod ending
XENE TTM Cash from Operations (-$3.32M → -$337.52M)
TTM operating cash flow (statement)
High-resolution chart · PNG
XENE operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -337,520,000 | |
| -306,363,000 | |
| -279,118,000 | |
| -252,022,000 | |
| -229,935,000 | |
| -198,381,000 | |
| -182,916,000 | |
| -163,996,000 | |
| -156,561,000 | |
| -157,103,000 | |
| -145,327,000 | |
| -142,594,000 | |
| -130,766,000 | |
| -114,413,000 | |
| -98,430,000 | |
| -86,408,000 | |
| -71,013,000 | |
| -67,222,000 | |
| -69,502,000 | |
| -61,906,000 | |
| -58,873,376 | |
| -56,237,597 | |
| -48,596,597 | |
| -15,747,597 | |
| -10,840,221 | |
| -9,032,000 | |
| -4,632,000 | |
| -31,609,000 | |
| -38,267,000 | |
| -35,172,000 | |
| -34,724,000 | |
| -34,320,000 | |
| -29,221,000 | |
| -30,485,000 | |
| -28,726,000 | |
| -26,558,000 | |
| -22,456,000 | |
| -21,083,000 | |
| -19,567,000 | |
| -20,144,000 | |
| -20,505,000 | |
| -17,500,000 | |
| -18,103,000 | |
| -15,807,000 | |
| -4,638,000 | |
| -4,439,000 | |
| 266,000 | |
| 531,000 | |
| -775,000 | |
| -1,357,000 | |
| -3,322,000 | |
| 19,077,500 | |
| 33,813,000 |